Global Epilepsy Drug Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026
- ID:PD008818
- March 2020
- Value Market Research
The report on the Global Epilepsy Drug Market gives an estimation of the development of the market based on historical studies and also provides forecasts on the basis of comprehensive research. The report gives a complete market analysis for the forecasted period from 2020 to 2026. The market is portioned into various segments with an in-depth outlook of the competitive outlook and a listing of the profiled key players. The market size in terms of revenue (USD MN) is calculated and provided for the study period along with the dynamics of the market such as the drivers and the restraints.
Study period considered for research of global epilepsy drug market:
- Base Year: 2019
- Estimated Year: 2020
- Forecast Till: 2026
A glimpse of the major drivers and restraints affecting the epilepsy drug market is mentioned below:
Drivers
- Rising incidence of neurological disorders
- Increasing road accident
- Higher incidence of birth related injuries
Restraints
- High cost of patented drugs
- Low accessibility to antiepileptic drugs in low and middle income countries
The report offers a value chain analysis that gives a comprehensive outlook of the epilepsy drug market. The attractiveness analysis of this market has also been included so as to evaluate the segments that are anticipated to be profitable during the forecast period.
The epilepsy drug market has been segmented based on drug types such as marketed drugs and pipeline drugs. The study incorporates periodic market estimates and forecasts. Each drug type has been analyzed based on the market size at regional and country levels. Further, marketed drugs has been segmented into first generation drug, second generation drug and third generation drug. First generation drugs has been further segmented into phenytoin, carbamazepine, oxycarbazepine, valproate, ethosuximide, primidone and phenobarbital. Second generation drugs has been segmented into levetiracetam, lamotrigine, topiramate, pregabalin, rufinamide and zonisamide. Third generation drugs has been further segmented into lacosamide, perampanel, eslicarbazepine acetate and ezogabine/retigabine.
Geographically, the epilepsy drug market has been segmented into regions such as North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The study details country-level aspects based on each segment and gives estimates in terms of market size.
The report also covers the complete competitive landscape of the global Epilepsy Drug market with company profiles of key players such as:
- Abbott Laboratories
- Eisai Co. Ltd
- GlaxoSmithKline plc
- Novartis AG
- Pfizer, Inc.
- Sanofi S.A.
- Sunovion Pharmaceuticals Inc.
- Teva Pharmaceutical Industries Ltd.
- UCB S.A.
A detailed description of each has been included, with information in terms of headquarters, inception, stock listing, upcoming capacities, key mergers & acquisitions, financial overview, and recent developments. This analysis gives a thorough idea about the competitive positioning of market players. The report also gives information of epilepsy drug market’s mergers/acquisitions, partnerships, collaborations, new product launches, new product developments and other industry developments.
SEGMENTATIONS IN REPORT:
Epilepsy drug Market Analysis by Drug Type:
- Marketed Drugs
- First Generation Drugs
- Phenytoin
- Carbamazepine
- Oxycarbazepine
- Valproate
- Ethosuximide
- Primidone
- Phenobarbital
- Second Generation Drugs
- Levetiracetam
- Lamotrigine
- Topiramate
- Pregabalin
- Rufinamide
- Zonisamide
- Third Generation Drugs
- Lacosamide
- Perampanel
- Eslicarbazepine Acetate
- Ezogabine/Retigabine
- First Generation Drugs
- Pipeline Drugs
Epilepsy drug Market Analysis by Geography:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East And Africa
The Global Epilepsy Drug Market has been exhibited in detail in the following chapters -
Chapter 1 Epilepsy Drug Market Preface
Chapter 2 Executive Summary
Chapter 3 Epilepsy Drug Industry Analysis
Chapter 4 Epilepsy Drug Market Value Chain Analysis
Chapter 5 Epilepsy Drug Market Analysis By Drug Type
Chapter 6 Epilepsy Drug Market Analysis By Geography
Chapter 7 Competitive Landscape Of Epilepsy Drug Companies
Chapter 8 Company Profiles Of Epilepsy Drug Industry
METHODOLOGY:
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.
- DecisionDatabases.com also provides specific research reports as per Client requirement.
- Based on the feasibility, data can be provided for custom segmentation
DELIVERABLE OPTIONS:
DecisionDatabases.com also provides Mini Report and Sections of Reports, in case Client does not want to buy the full report:
- Market Data Sheet with all Tables and Graphs
- Mini Report
- Market Analysis
- Drivers
- Restraints
- SWOT Analysis
- Patent Analysis
- Application Analysis
- Product Analysis
- Geography Analysis
- Company Analysis
- Competitive Landscape
- Location of Plants
- Company Profiles
TABLE OF CONTENTS
1 . PREFACE
1.1. Report Description
1.1.1. Objective
1.1.2. Target Audience
1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
2.1. Highlights of Epilepsy Drug Market
2.2. Global Epilepsy Drug Market Snapshot
3 . EPILEPSY DRUG – INDUSTRY ANALYSIS
3.1. Introduction
3.2. Market Drivers of Epilepsy Drug Market
3.3. Market Restraints of Epilepsy Drug Market
3.4. Opportunities of Epilepsy Drug Market
3.5. Trends of Epilepsy Drug Market
3.6. Porter’s Five Force Analysis of Epilepsy Drug Market
3.7. Epilepsy Drug Market Attractiveness Analysis
3.7.1 Market Attractive Analysis by Drug Type
3.7.2 Market Attractive Analysis by Region
4 . VALUE CHAIN ANALYSIS
4.1. Epilepsy Drug Value Chain Analysis
4.2. Epilepsy Drug Raw Material Analysis
4.2.1. List of Raw Materials
4.2.2. Epilepsy Drug Raw Material Manufactures List
4.2.3. Price Trend of Epilepsy Drug Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1. Direct Marketing
4.4.2. Indirect Marketing
4.4.3. Marketing Channel Development Trend
5 . GLOBAL EPILEPSY DRUG MARKET ANALYSIS BY DRUG TYPE
5.1 Overview by Drug Type
5.2 Global Epilepsy Drug Market Analysis by Drug Type
5.3 Market Analysis of Marketed Drugs by Regions
5.4 Market Analysis of Pipeline Drugs by Regions
6 . GLOBAL EPILEPSY DRUG MARKET ANALYSIS BY GEOGRAPHY
6.1. Regional Outlook
6.2. Introduction
6.3. North America
6.3.1. Overview
6.3.2. North America Epilepsy Drug Market Estimate by Market Segment
6.3.3. North America Epilepsy Drug Market Estimate by Country
6.3.4. United State
6.3.5. Rest of North America
6.4. Europe
6.4.1. Overview
6.4.2. Europe Epilepsy Drug Market Estimate by Market Segment
6.4.3. Europe Epilepsy Drug Market Estimate by Country
6.4.4. United Kingdom
6.4.5. France
6.4.6. Germany
6.4.6 Rest of Europe
6.5. Asia Pacific
6.5.1. Overview
6.5.2. Asia Pacific Epilepsy Drug Market Estimate by Market Segment
6.5.3. Asia Pacific Epilepsy Drug Market Estimate by Country
6.5.4. China
6.5.5. Japan
6.5.6. India
6.5.6. Rest of Asia Pacific
6.6. Latin America
6.6.1. Overview
6.6.2. Latin America Epilepsy Drug Market Estimate by Market Segment
6.6.3. Latin America Epilepsy Drug Market Estimate by Country
6.6.4. Brazil
6.6.5. Rest of Latin America
6.7. Middle East & Africa
6.7.1. Overview
6.7.2. Middle East & Africa Epilepsy Drug Market Estimate by Market Segment
6.7.3. Middle East & Africa Epilepsy Drug Market Estimate by Country
6.7.4. Middle East
6.7.5. Africa
7 . COMPETITIVE LANDSCAPE OF THE EPILEPSY DRUG COMPANIES
7.1. Epilepsy Drug Market Competition
7.2. Partnership/Collaboration/Agreement
7.3. Merger And Acquisitions
7.4. New Product Launch
7.5. Other Developments
8 . COMPANY PROFILES OF EPILEPSY DRUG INDUSTRY
8.1. Company Share Analysis
8.2. Market Concentration Rate
8.3. Abbott Laboratories
8.3.1. Company Overview
8.3.2. Financials
8.3.3. Products
8.3.4. Recent Developments
8.4. Eisai Co. Ltd
8.4.1. Company Overview
8.4.2. Financials
8.4.3. Products
8.4.4. Recent Developments
8.5. GlaxoSmithKline plc
8.5.1. Company Overview
8.5.2. Financials
8.5.3. Products
8.5.4. Recent Developments
8.6. Novartis AG
8.6.1. Company Overview
8.6.2. Financials
8.6.3. Products
8.6.4. Recent Developments
8.7. Pfizer, Inc.
8.7.1. Company Overview
8.7.2. Financials
8.7.3. Products
8.7.4. Recent Developments
8.8. Sanofi S.A.
8.8.1. Company Overview
8.8.2. Financials
8.8.3. Products
8.8.4. Recent Developments
8.9. Sunovion Pharmaceuticals Inc.
8.9.1. Company Overview
8.9.2. Financials
8.9.3. Products
8.9.4. Recent Developments
8.10. Teva Pharmaceutical Industries Ltd.
8.10.1. Company Overview
8.10.2. Financials
8.10.3. Products
8.10.4. Recent Developments
8.11. UCB S.A.
8.11.1. Company Overview
8.11.2. Financials
8.11.3. Products
8.11.4. Recent Developments
*Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
LIST OF TABLES
- Global Epilepsy Drug Market Snapshot
- Drivers of The Global Epilepsy Drug Market Impact Analysis
- Restraints of The Global Epilepsy Drug Market Impact Analysis
- List of Raw Material
- List of Raw Material Manufactures
- List of Potential Buyers
- Global Epilepsy Drug Market Analysis by Drug Type (USD MN)
- Global Epilepsy Drug Market Analysis in Marketed Drugs by Geography (USD MN)
- Global Epilepsy Drug Market Analysis in Pipeline Drugs by Geography (USD MN)
- Global Epilepsy Drug Market by Geography (USD MN)
- North America Epilepsy Drug Market Analysis by Drug Type (USD MN)
- North America Epilepsy Drug Market Estimate by Country (USD MN)
- United State Epilepsy Drug Market Analysis by Drug Type (USD MN)
- Rest of North America Epilepsy Drug Market Analysis by Drug Type (USD MN)
- Europe Epilepsy Drug Market Analysis by Drug Type (USD MN)
- United Kingdom Epilepsy Drug Market Analysis by Drug Type (USD MN)
- France Epilepsy Drug Market Analysis by Drug Type (USD MN)
- Germany Epilepsy Drug Market Analysis by Drug Type (USD MN)
- Rest of Europe Epilepsy Drug Market Analysis by Drug Type (USD MN)
- Asia Pacific Epilepsy Drug Market Analysis by Drug Type (USD MN)
- Asia Pacific Epilepsy Drug Market Estimate by Country (USD MN)
- China Epilepsy Drug Market Analysis by Drug Type (USD MN)
- Japan Epilepsy Drug Market Analysis by Drug Type (USD MN)
- India Epilepsy Drug Market Analysis by Drug Type (USD MN)
- Rest of Asia Pacific Epilepsy Drug Market Analysis by Drug Type (USD MN)
- Latin America Epilepsy Drug Market Analysis by Drug Type (USD MN)
- Latin America Epilepsy Drug Market Estimate by Country (USD MN)
- Brazil Epilepsy Drug Market Analysis by Drug Type (USD MN)
- Rest of Latin America Epilepsy Drug Market Analysis by Drug Type (USD MN)
- Middle East & Africa Epilepsy Drug Market Estimate by Drug Type (USD MN)
- Middle East & Africa Epilepsy Drug Market Estimate by Country (USD MN)
- Middle East Epilepsy Drug Market Analysis by Drug Type (USD MN)
- Africa Epilepsy Drug Market Analysis by Drug Type (USD MN)
- Partnership/Collaboration/Agreement
- Mergers And Acquisiton
- New Product Launch
- Other Developments
- Company Market Share Analysis, 2019
LIST OF FIGURES
- Research Scope of Epilepsy Drug Report
- Market Research Process
- Market Research Methodology
- Global Epilepsy Drug Market Size, by Region (USD MN)
- Porters Five Forces Analysis
- Market Attractiveness Analysis by Drug Type
- Market Attractiveness Analysis by Region
- Value Chain Analysis
- Global Epilepsy Drug Market Analysis by Drug Type (USD MN)
- Global Epilepsy Drug Market Analysis in Marketed Drugs by Geography (USD MN)
- Global Epilepsy Drug Market Analysis in Pipeline Drugs by Geography (USD MN)
- Latin America Epilepsy Drug Market by Revenue
- Middle East & Africa Epilepsy Drug Market by Revenue
- Recent Development in Epilepsy Drug Industry
- Company Market Share Analysis, 2019
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.
The report on the Global Tigecycline Market gives an estimation of the development of the market based on historical studies and also provides forecasts read more..
Global Risperidone Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
The Global Risperidone Market Report is equipped with market data from 2015 to 2025. The report gives a market overview covering key drivers and risks read more..
Global Caffeine Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027
The report on the Global Caffeine Market gives an estimation of the development of the market based on historical studies and also provides forecasts on read more..
Global Rabies Vaccine Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027
The report on the Global Rabies Vaccine Market gives an estimation of the development of the market based on historical studies and also provides read more..
Global Radiopharmaceuticals Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027
The report on the Global Radiopharmaceuticals Market gives an estimation of the development of the market based on historical studies and also provides read more..
Global Neurorehabilitation System Market Research Report
The report on the Global Neurorehabilitation System Market gives an estimation of the development of the market based on historical studies and also read more..
Global Molecular Biology Kits And Reagents Market Research Report
The report on the Global Molecular Biology Kits And Reagents Market gives an estimation of the development of the market based on historical studies and read more..
Global High Acuity Care Information Systems Market Research Report
The report on the Global High Acuity Care Information Systems Market gives an estimation of the development of the market based on historical studies and read more..
Global Regenerative Medicine Market Research Report
The global regenerative medicine market was estimated to be at ~$4.5 billion in 2013. A number of factors such as increasing bone related read more..
Global Skin Cancer Diagnostics Market Research Report
The report on the Global Skin Cancer Diagnostics Market gives an estimation of the development of the market based on historical studies and also read more..